Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis.

Dr. Danoff is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine and Co-Director of the Hopkins Interstitial Lung Disease Clinic. She is a specialist in diseases causing fibrosis or scarring in the lung, particularly those associated with autoimmune diseases including myositis. Dr. Danoff is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Endoscopy, and Lung Transplant.

Mohammad Rahnama is a primary care provider, practicing in Internal Medicine in Parkville, Maryland. Dr. Rahnama is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are High Cholesterol, Familial Combined Hyperlipidemia, Xanthoma, and Cirrhosis.

Audrey Liu is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Liu is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Obstructive Sleep Apnea, Squamous Cell Lung Carcinoma, and Advanced Bronchoscopy. Dr. Liu is currently accepting new patients.

Howard Freeland is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Freeland is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Lung Metastases, Pulmonary Veno-Occlusive Disease, Pulmonary Hypertension, and Chronic Obstructive Pulmonary Disease (COPD).

Mitchell Schwartz is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Towson, Maryland. Dr. Schwartz is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Lung Metastases, Hospital-Acquired Pneumonia, Atypical Pneumonia, Neurosarcoidosis, and Gastrostomy. Dr. Schwartz is currently accepting new patients.

Linda Barr is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Towson, Maryland. Dr. Barr is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Lung Metastases, Bronchiectasis, Asthma, Gastrostomy, and Endoscopy. Dr. Barr is currently accepting new patients.

Carlos Baleeiro is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Baleeiro is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Tracheitis, Gastrostomy, and Ureteroscopy. Dr. Baleeiro is currently accepting new patients.

Martin Sheridan is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Sheridan is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Lung Metastases, Asbestosis, Emphysema, and Chronic Obstructive Pulmonary Disease (COPD). Dr. Sheridan is currently accepting new patients.

Ji Rhee is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Rhee is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Asthma, and Asthma in Children. Dr. Rhee is currently accepting new patients.

Michael Randolph is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Randolph is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are End-Stage Renal Disease (ESRD), Hypertensive Heart Disease, Enlarged Liver, and Pediatric Myocarditis. Dr. Randolph is currently accepting new patients.

Dr. Sarath Raju is an instructor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include obstructive lung diseases (asthma, chronic obstructive pulmonary disease), chronic lung disease in persons living with HIV, and critical care medicine. Dr. Raju earned his M.D. from Rush Medical College. He completed his residency at Johns Hopkins, where he also performed a fellowship in pulmonary and critical care medicine. He previously served as an Assistant Chief of Service for the Osler Medical Housestaff Training Program at Johns Hopkins. Dr. Raju joined the Johns Hopkins faculty in 2020, and is supported by the NIH to conduct research investigating the intersection of HIV, environmental exposures, and lung health. Dr. Raju is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Bronchogenic Cyst, Lung Metastases, Bronchitis, and Endoscopy.

Dr. Buescher is a pulmonary critical care physician. He has been deeply involved in clinical teaching of both medical students, interns, residents and fellows throughout his career. He is the director of the Medical/Surgical Critical Care Units at MedStar Union Memorial Hospital as well as MedStar Good Samaritan Hospital. He is president of a large community private practice pulmonary and critical group (Pulmonary and Critical Care Associates of Baltimore) He serves at Hopkins on the part-time clinical faculty. Research Summary Dr. Buescher is involved in multiple clinical research projects. Dr. Buescher is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Lung Metastases, Endoscopy, and Gastrostomy.

Dr. Howard Steiner is an instructor of medicine at the Johns Hopkins School of Medicine. He has been practicing pulmonary and sleep consultative medicine since 1989. In his role as a diagnostician, he guides the evaluation and management of respiratory problems including infectious, malignant, allergic, autoimmune, and sleep-related disorders. He has been part-time faculty in the Johns Hopkins Pulmonary Division since 1991, is a Fellow in the American College of Chest Physicians, and mentors medical students, residents, and pulmonary fellows training at the Johns Hopkins Hospital. Contact for Research Inquiries 10755 Falls Road Pavilion I, Suite 200 Lutherville, MD 21093 Phone: (410) 583-7124 Selected Publications Lwebuga-Mukasa JS, Steiner H. Monoclonal antibody to rat lung Maclura Pomifera agglutinin (MPA) lectin binding glycoprotein localizes apically on rat and human type II pneumocytes and Clara cells. J Cell Biol 107:71a, 1989. Roberts PJ, McBean GJ, Steiner H, Kohler C, Schwarcz R. Lesioning Effects of Ibotenate in the immature rat brain and protection by 2-amino-7 phosphonoheptanoic acid. Soc Neurosci Abst 9:261, 1983. Steiner H, Ingbar DI. Mechanisms of lung injury and repair. In: Matthay RA, Matthay MA, Wiedemann HP eds. Annual Review of Pulmonary and Critical Care Medicine. Hanley & Belfus (Philadelphia, 1989), pp 205-223. Steiner H, Lwebuga-Mukasa JS. A549 cells display distinct functional and morphologic properties depending on their culture substratum. J Cell Biol 107:71a, 1989. Steiner H, Lwebuga-Mukasa JS. A549 cells produce a factor which is Mitogenic for human lung fibroblasts. Amer Rev Resp Dis 139:A492 1989. Steiner H, McBean GJ, Kohler C, Roberts PJ, Schwarcz R. Ibotenate Induced neuronal degeneration in immature rat brain. Brain Research 307:117-124, 1984. Dr. Steiner is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Bronchiectasis, Obstructive Sleep Apnea, Lung Metastases, and Interstitial Lung Disease.

Stacey-ann Brown is a Pulmonary Medicine provider in Lutherville, Maryland. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Hypersensitivity Pneumonitis, and Cholesterol Pneumonia.

Dr. Karthik Suresh is a pulmonary and critical care physician. His clinical interests include acute lung injury and critical care medicine. He also specializes in the diagnosis and management of immune-related lung injury, especially in the context of autoimmune conditions and chemotherapy/immunotherapy for cancer. Dr. Suresh is a member of the Hopkins immune-related adverse events (irAE) tox team. He also takes care of critically ill patients in the medical and oncology ICUs. He’s a firm faculty member for the Janeway Firm of the Osler Housestaff Medical Service and provides teaching to medical students, housestaff and fellows. Dr. Suresh is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pneumonia, and Lung Metastases.

Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

Dr. Chen practices Pulmonary and Critical Care Medicine. His primary area of interest is sarcoidosis, and he has extensive experience in the diagnosis and treatment of sarcoidosis in all of its forms, and the management of consequences of this systemic disease. The Sarcoidosis Clinic often serves to coordinate management of patients with multi-organ involvement with sarcoidosis, and to this end Dr. Chen actively maintains clinical and research collaborations with Cardiology, Cardiovascular Nuclear Medicine, Neurology, and Ophthalmology. Additionally, Dr. Chen participates as a Physician Champion in the Johns Hopkins Health System Epic project to improve the safety and quality of care of critically ill patients through optimization of the electronic medical record. His work involves developing systems-based approaches to complex management issues, including sepsis and severe alcohol withdrawal. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Lung Metastases, and Acute Interstitial Pneumonia.

Dr. Liu is a pulmonary physician with additional expertise in allergy and immunology. He is an expert in the diagnosis and treatment of patients with severe asthma with a focus on developing new treatments for severe disease that has failed to respond to standard therapies. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Eosinophilic Asthma, Chronic Eosinophilic Pneumonia, Eosinophilic Pneumonia, Simple Pulmonary Eosinophilia, and Gastrostomy.

Dr. Gregory Diette is a professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in the Department of Epidemiology in the Johns Hopkins Bloomberg School of Public Health. He has over 20 years of experience diagnosing and managing complex and challenging pulmonary conditions. He is expert in the diagnosis and treatment of patients with common conditions such as asthma and COPD, as well as uncommon conditions such as allergic bronchopulmonary aspergillosis (ABPA), bronchiolitis obliterans, hypersensitivity pneumonitis and others. His practice includes evaluation of patients with unexplained shortness of breath and cough as well as patients with a variety of environmental lung conditions. In addition to his outpatient practice, Dr. Diette provides inpatient care on the pulmonary, critical care and internal medicine services. Dr. Diette earned his M.D. from the Temple University School of Medicine. He completed his residency at the Hospital of the University of Pennsylvania and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. He received his M.H.S. from the Johns Hopkins Bloomberg School of Public Health. His research interests include environmental impacts on lung disease, epidemiology of airway disease and chronic obstructive pulmonary disease. Dr. Diette is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Asthma, Allergic Bronchopulmonary Aspergillosis, Pulmonary Aspergilloma, and Aspergillosis.